286 related articles for article (PubMed ID: 14751503)
1. Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non-small-cell lung cancer cells.
Zhang M; Boyer M; Rivory L; Hong A; Clarke S; Stevens G; Fife K
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):353-60. PubMed ID: 14751503
[TBL] [Abstract][Full Text] [Related]
2. Radiosensitization with chemotherapeutic agents.
Caffo O
Lung Cancer; 2001 Dec; 34 Suppl 4():S81-90. PubMed ID: 11742709
[TBL] [Abstract][Full Text] [Related]
3. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer.
Lee DH; Han JY; Cho KH; Pyo HR; Kim HY; Yoon SJ; Lee JS
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1037-44. PubMed ID: 16024178
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of radiation therapy by vinorelbine (Navelbine) in non-small cell lung cancer.
Edelstein MP; Wolfe LA; Duch DS
Semin Oncol; 1996 Apr; 23(2 Suppl 5):41-7. PubMed ID: 8610236
[TBL] [Abstract][Full Text] [Related]
6. Metuzumab enhanced chemosensitivity and apoptosis in non-small cell lung carcinoma.
Feng F; Wang B; Sun X; Zhu Y; Tang H; Nan G; Wang L; Wu B; Huhe M; Liu S; Diao T; Hou R; Zhang Y; Zhang Z
Cancer Biol Ther; 2017 Jan; 18(1):51-62. PubMed ID: 28055291
[TBL] [Abstract][Full Text] [Related]
7. [Concomitant radiochemotherapy for non-small-cell lung cancer: towards an ideal strategy].
Rixe O
Rev Mal Respir; 2001 Sep; 18(4 Pt 1):365-6. PubMed ID: 11547240
[No Abstract] [Full Text] [Related]
8. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
Argiris A; Liptay M; LaCombe M; Marymont M; Kies MS; Sundaresan S; Masters G
Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197
[TBL] [Abstract][Full Text] [Related]
9. In vitro schedule-dependent interaction between irinotecan and vinorelbine in NCI H460 non-small cell lung cancer cell line.
Gauvin A; Bressolle F; Martineau P; Astre C; Pinguet F
Anticancer Res; 2002; 22(2A):905-12. PubMed ID: 12014670
[TBL] [Abstract][Full Text] [Related]
10. The role of radiation, with or without chemotherapy, in the management of NSCLC.
Chakravarthy A; Johnson D; Choy H
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):93-100. PubMed ID: 10550832
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer: a phase I study.
Gagel B; Piroth M; Pinkawa M; Reinartz P; Zimny M; Fischedik K; Stanzel S; Breuer C; Skobel E; Asadpour B; Schmachtenberg A; Buell U; Eble MJ
Strahlenther Onkol; 2006 May; 182(5):263-9. PubMed ID: 16673059
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431.
Vokes EE; Herndon JE; Crawford J; Leopold KA; Perry MC; Miller AA; Green MR
J Clin Oncol; 2002 Oct; 20(20):4191-8. PubMed ID: 12377962
[TBL] [Abstract][Full Text] [Related]
13. Vinorelbine: a review of its use in elderly patients with advanced non-small cell lung cancer.
Curran MP; Plosker GL
Drugs Aging; 2002; 19(9):695-721. PubMed ID: 12381238
[TBL] [Abstract][Full Text] [Related]
14. The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.
Herbst RS; Khuri FR; Lu C; Liu DD; Fossella FV; Glisson BS; Pisters KM; Shin DM; Papadimitrakopoulou VA; Kurie JM; Blumenschein G; Kies MS; Zinner R; Jung MS; Lu R; Lee JJ; Munden RF; Hong WK; Lee JS
Cancer; 2002 Jul; 95(2):340-53. PubMed ID: 12124835
[TBL] [Abstract][Full Text] [Related]
15. Docetaxel (Taxotere) in combination chemotherapy and in association with thoracic radiotherapy for the treatment of non-small-cell lung cancer. Thoracic Oncology Program.
Ornstein DL; Nervi AM; Rigas JR
Ann Oncol; 1999; 10 Suppl 5():S35-40. PubMed ID: 10582137
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter.
Juergens R; Brahmer J; Ettinger D
Cancer Chemother Pharmacol; 2007 Apr; 59(5):621-9. PubMed ID: 16937106
[TBL] [Abstract][Full Text] [Related]
17. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review.
Clegg A; Scott DA; Hewitson P; Sidhu M; Waugh N
Thorax; 2002 Jan; 57(1):20-8. PubMed ID: 11809985
[TBL] [Abstract][Full Text] [Related]
18. Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Billings FT; Bradof JE; Baker M; Greco FA
Cancer; 2001 Nov; 92(9):2391-8. PubMed ID: 11745295
[TBL] [Abstract][Full Text] [Related]
19. Combination chemoradiotherapy with gemcitabine: potential applications.
Choy H
Oncology (Williston Park); 2000 Jul; 14(7 Suppl 4):20-5. PubMed ID: 10960941
[TBL] [Abstract][Full Text] [Related]
20. [Rational and results of a scheduled sequential combination in advanced non-small cell lung carcinoma].
Amadio P; Panebianco V; Priolo D; D'Angelo A; Calì S; Antonelli G; Ferraù F
Suppl Tumori; 2004; 3(2):S38-41. PubMed ID: 15067965
[No Abstract] [Full Text] [Related]
[Next] [New Search]
